Skip to content
Facebook Twitter Linkedin
InMed-logo-01
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn
  • Pharmaceutical
    • INM-901 for Alzheimer’s Disease
    • INM-089 for Age-related Macular Degeneration
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Analogs
  • Manufacturing
    • BayMedica – Rare Cannabinoid Ingredients
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
  • Investors
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM Materials
    • Filings
    • Presentations
    • Media and Videos
    • Investor Contact
  • Corporate
    • Management
    • Board of Directors
    • Scientific Advisors
    • Partners and Collaborators
    • Careers
    • Contact
  • Learn

Filings

Form TypeForm DescriptionFiling DateReport DateView Report
8-KCurrent report2024-09-262024-09-26
8-KCurrent report2024-09-202024-09-17
8-KCurrent report2024-08-212024-08-21
8-KCurrent report2024-08-202024-08-20
4Statement of changes in beneficial ownership of securities2024-08-022024-07-31
8-KCurrent report2024-07-302024-07-30
8-KCurrent report2024-06-282024-06-27
8-KCurrent report2024-06-282024-06-27
424B3Prospectus [Rule 424(b)(3)]2024-06-28
8-KCurrent report2024-06-112024-06-10
4Statement of changes in beneficial ownership of securities2024-05-282024-05-27
4Statement of changes in beneficial ownership of securities2024-05-282024-05-27
10-QQuarterly report [Sections 13 or 15(d)]2024-05-142024-03-31
8-KCurrent report2024-05-142024-05-14
8-KCurrent report2024-04-182024-04-18
8-KCurrent report2024-04-162024-04-16
8-KCurrent report2024-04-052024-04-04
8-KCurrent report2024-03-202024-03-19
4Statement of changes in beneficial ownership of securities2024-03-052024-03-04
4Statement of changes in beneficial ownership of securities2024-03-052024-01-21
4Statement of changes in beneficial ownership of securities2024-03-052024-01-14
3Initial statement of beneficial ownership of securities2024-02-272024-02-20
4Statement of changes in beneficial ownership of securities2024-02-222024-02-21
4Statement of changes in beneficial ownership of securities2024-02-212024-02-20
8-KCurrent report2024-02-142024-02-13
SC 13G/AStatement of acquisition of beneficial ownership by individuals - amended2024-02-14
10-QQuarterly report [Sections 13 or 15(d)]2024-02-132023-12-31
8-KCurrent report2024-02-092024-02-08
8-KCurrent report2024-01-192024-01-18
8-KCurrent report2024-01-162024-01-16
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next »

Investor Alerts

Sign up for investor alerts!
Sign Up

Information Request

Send us a request for information
Learn More
InMed-logo-mono

#1445 – 885 West Georgia St.
Vancouver, BC, Canada
V6C 3E8

Pharmaceutical

  • INM-901 for Alzheimer’s Disease
  • INM-089 for Age-related Macular Degeneration
  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • Novel Analogs

MANUFACTURING

  • BayMedica – Rare Cannabinoid Ingredients
  • Cannabinoid Manufacturing Expertise
  • IntegraSyn™ Cannabinoid Manufacturing

Investor

  • News
  • Events
  • Stock Information
  • Corporate Governance
  • Financials & AGM Materials
  • Filings
  • Presentations
  • Media & Videos
  • Investor Contact

CORPORATE

  • Management
  • Board of Directors
  • Scientific Advisors
  • Partners and Collaborators
  • Careers
  • Contact

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • Cannabinoid Manufacturing Economics 101
  • GMP Manufacturing Standards by Product Type
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2025 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On:
Subscribe

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*
Consent*